Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,978 | -9,075 | -6,201 | -3,261 | -13,316 |
| Depreciation Amortization | 872 | 544 | 345 | 171 | 818 |
| Other Working Capital | 3,222 | 849 | 1,005 | -1,601 | -1,116 |
| Other Operating Activity | -1,670 | -1,661 | -812 | 178 | 763 |
| Operating Cash Flow | $-10,554 | $-9,343 | $-5,663 | $-4,513 | $-12,851 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,420 | -3,495 | -3,500 | -324 | N/A |
| PPE Investments | -146 | -135 | -121 | -40 | -160 |
| Purchase Sale Intangibles | -545 | -545 | -545 | N/A | N/A |
| Other Investing Activity | -545 | -545 | -545 | 0 | 0 |
| Investing Cash Flow | $-4,111 | $-4,175 | $-4,166 | $-364 | $-160 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,292 | 3,292 | 3,292 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | -402 | N/A |
| Debt Repayment | -3,996 | -3,996 | -3,996 | N/A | -1,608 |
| Common Stock Issued | 7,265 | 7,265 | 7,310 | N/A | 5,527 |
| Common Stock Repurchased | -374 | -374 | -374 | -374 | -126 |
| Other Financing Activity | 0 | 0 | -45 | 0 | -348 |
| Financing Cash Flow | $6,187 | $6,187 | $6,187 | $-776 | $3,445 |
| Beginning Cash Position | 8,554 | 8,554 | 8,554 | 8,554 | 18,120 |
| End Cash Position | 76 | 1,223 | 4,912 | 2,901 | 8,554 |
| Net Cash Flow | $-8,478 | $-7,331 | $-3,642 | $-5,653 | $-9,566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,554 | -9,343 | -5,663 | -4,513 | -12,851 |
| Capital Expenditure | -146 | -135 | -121 | -40 | -160 |
| Free Cash Flow | -10,700 | -9,478 | -5,784 | -4,553 | -13,011 |